These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31450958)

  • 21. Information on adverse events in randomised clinical trials assessing drug interventions published in four medical journals with high impact factors.
    Maggi CB; Griebeler IH; Dal Pizzol Tda S
    Int J Risk Saf Med; 2014; 26(1):9-22. PubMed ID: 24796347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to unpublished protocols and statistical analysis plans of randomised trials.
    Campbell D; McDonald C; Cro S; Jairath V; Kahan BC
    Trials; 2022 Aug; 23(1):674. PubMed ID: 35978391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Data Sharing After Implementation of the International Committee of Medical Journal Editors Data Sharing Statement Requirement.
    Danchev V; Min Y; Borghi J; Baiocchi M; Ioannidis JPA
    JAMA Netw Open; 2021 Jan; 4(1):e2033972. PubMed ID: 33507256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals.
    Berwanger O; Ribeiro RA; Finkelsztejn A; Watanabe M; Suzumura EA; Duncan BB; Devereaux PJ; Cook D
    J Clin Epidemiol; 2009 Apr; 62(4):387-92. PubMed ID: 19010643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocol adherence rates in superiority and noninferiority randomized clinical trials published in high impact medical journals.
    Bamat NA; Ekhaguere OA; Zhang L; Flannery DD; Handley SC; Herrick HM; Ellenberg SS
    Clin Trials; 2020 Oct; 17(5):552-559. PubMed ID: 32666826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between publicly accessible publications, registries, and protocols of phase III trials indicated persistence of selective outcome reporting.
    Zhang S; Liang F; Li W
    J Clin Epidemiol; 2017 Nov; 91():87-94. PubMed ID: 28757260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials.
    Liang F; Guo X; Zhang S; Xue H; Chen Q; Hu X
    Oncotarget; 2017 Nov; 8(57):97648-97656. PubMed ID: 29228640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discussion sections in reports of controlled trials published in general medical journals.
    Clarke M; Alderson P; Chalmers I
    JAMA; 2002 Jun; 287(21):2799-801. PubMed ID: 12038916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between protocols and publications for prognostic and predictive cancer biomarker studies.
    Doussau A; Vinarov E; Barsanti-Innes B; Kimmelman J
    Clin Trials; 2020 Feb; 17(1):61-68. PubMed ID: 31588779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic review.
    Gewandter JS; Kitt RA; Hunsinger MR; Poku J; Lozano J; Chaudari J; Evans S; Gross RA; McDermott MP; Rowbotham MC; Turk DC; Dworkin RH
    J Clin Epidemiol; 2017 Mar; 83():101-107. PubMed ID: 28126598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [German publications in leading English language journals].
    Maleck WH; Boldt J; Koetter KP
    Dtsch Med Wochenschr; 2001 Jan; 126(3):33-41. PubMed ID: 11205476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials.
    Sun X; Briel M; Busse JW; Akl EA; You JJ; Mejza F; Bala M; Diaz-Granados N; Bassler D; Mertz D; Srinathan SK; Vandvik PO; Malaga G; Alshurafa M; Dahm P; Alonso-Coello P; Heels-Ansdell DM; Bhatnagar N; Johnston BC; Wang L; Walter SD; Altman DG; Guyatt GH
    Trials; 2009 Nov; 10():101. PubMed ID: 19900273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in High-Impact Neurosurgical Randomized Controlled Trials Published in General Medical Journals: A Systematic Review.
    Karhade AV; Senders JT; Martin E; Muskens IS; Zaidi HA; Broekman MLD; Smith TR
    World Neurosurg; 2019 Sep; 129():e158-e170. PubMed ID: 31108256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.
    Raghav KP; Mahajan S; Yao JC; Hobbs BP; Berry DA; Pentz RD; Tam A; Hong WK; Ellis LM; Abbruzzese J; Overman MJ
    J Clin Oncol; 2015 Nov; 33(31):3583-90. PubMed ID: 26304898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical robustness of randomized controlled trials in high-impact journals has improved but was low across medical specialties.
    Kampman JM; Turgman O; Sperna Weiland NH; Hollmann MW; Repping S; Hermanides J
    J Clin Epidemiol; 2022 Oct; 150():165-170. PubMed ID: 35820586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalizability of findings from systematic reviews and meta-analyses in the Leading General Medical Journals.
    Malmivaara A
    J Rehabil Med; 2020 Mar; 52(3):jrm00031. PubMed ID: 32103277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Publication of Results of Registered Trials With Published Study Protocols, 2011-2022.
    Vorland CJ; Brown AW; Kilicoglu H; Ying X; Mayo-Wilson E
    JAMA Netw Open; 2024 Jan; 7(1):e2350688. PubMed ID: 38190185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Press Releases of Drug-Related Randomized Trial Results Prior to Publication in High-Impact Journals: an Observational Study.
    Purohit U; Sacks CA; Raissi A; Hughes E; Boctor M; Manzoor S; Hodzic-Santor B; Zhu K; Raudanskis A; Ross JS; Fralick M
    J Gen Intern Med; 2023 Nov; 38(14):3107-3114. PubMed ID: 37532876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Mandatory Prospective Trial Registration Working to Prevent Publication of Unregistered Trials and Selective Outcome Reporting? An Observational Study of Five Psychiatry Journals That Mandate Prospective Clinical Trial Registration.
    Scott A; Rucklidge JJ; Mulder RT
    PLoS One; 2015; 10(8):e0133718. PubMed ID: 26287998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Public availability and adherence to prespecified statistical analysis approaches was low in published randomized trials.
    Kahan BC; Ahmad T; Forbes G; Cro S
    J Clin Epidemiol; 2020 Dec; 128():29-34. PubMed ID: 32730852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.